ZBP1 as a prognostic biomarker correlated with cell proliferation in clear cell renal cell carcinoma
Our research findings suggest that targeting ZBP1 could represent a novel therapeutic approach to inhibit the progression of ccRCC.
Authors
- Qingtong Yi (ORCID: https://orcid.org/0000-0001-7167-3024)
- Tao Wang (ORCID: https://orcid.org/0000-0003-0934-7580)
- Daniyaerjiang Mutailipu
- Shengjie Liang
- Junjie Ma
- Rujian Zhu
- Yuqing Zhang (ORCID: https://orcid.org/0000-0001-8839-4849)
- Yang Li (ORCID: https://orcid.org/0000-0002-0112-1328)
Institutions
- Fudan University (CN)
- Soochow University (CN)
- Taixing People's Hospital (CN)
- Pudong Medical Center (CN)
- Taizhou First People's Hospital (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e39267
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42